Katarzyna Blachnio
Overview
Explore the profile of Katarzyna Blachnio including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
17
Citations
134
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Zajdel M, Szafron L, Paziewska A, Rymkiewicz G, Dabrowska M, Bystydzienski Z, et al.
Int J Mol Sci
. 2025 Jan;
26(1.
PMID: 39796140
High-grade B-cell lymphoma with 11q aberration (HGBCL-11q) is a rare germi-nal centre lymphoma characterised by a typical gain/loss pattern on chromo-some 11q but without MYC translocation. It shares some features...
2.
Woroniecka R, Rymkiewicz G, Bystydzienski Z, Pienkowska-Grela B, Rygier J, Malawska N, et al.
Mol Cytogenet
. 2023 Nov;
16(1):31.
PMID: 37941034
Background: Richter transformation (RT) is the development of aggressive lymphoma in patients with chronic lymphocytic leukemia (CLL) or small lymphocytic lymphoma (SLL). This rare disease is characterised by dismal prognosis....
3.
Blachnio K, Grygalewicz B, Woroniecka R, Rygier J, Pienkowska-Grela B, Rymkiewicz G, et al.
Folia Histochem Cytobiol
. 2022 Sep;
60(3):203-214.
PMID: 36045602
Introduction: Standard treatment for chronic lymphocytic leukemia (CLL) has experienced a dramatic change over the last few years. Until recently, CLL was treated using chemoimmunotherapy (CIT) with anti-CD20 monoclonal antibodies....
4.
Woroniecka R, Rymkiewicz G, Szafron L, Blachnio K, Szafron L, Bystydzienski Z, et al.
PLoS One
. 2022 Feb;
17(2):e0263980.
PMID: 35167621
The occurrence of MYC-negative Burkitt lymphoma (BL) has been discussed for many years. The real frequency of the MYC insertion in MYC-negative BL is still unknown. Fine-needle aspiration biopsies of...
5.
Jancewicz I, Szarkowska J, Konopinski R, Stachowiak M, Swiatek M, Blachnio K, et al.
Cancers (Basel)
. 2021 Aug;
13(16).
PMID: 34439305
Growing tumors avoid recognition and destruction by the immune system. During continuous stimulation of tumor-infiltrating lymphocytes (TILs) by tumors, TILs become functionally exhausted; thus, they become unable to kill tumor...
6.
Ostrowska B, Rymkiewicz G, Chechlinska M, Blachnio K, Domanska-Czyz K, Bystydzienski Z, et al.
Cancers (Basel)
. 2021 Apr;
13(8).
PMID: 33921074
(1) Background: T-cell lymphoblastic lymphoma (T-LBL) is extremely rare and highly aggressive, with no practical risk model defined yet. The prognostic value of T-LBL immunological subtypes is still a matter...
7.
Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Malawska N, Blachnio K, et al.
Cancer Genet
. 2020 Jun;
245:1-5.
PMID: 32531723
"Burkitt-like lymphoma with 11q aberration" is a new provisional entity in the latest revision of lymphoma's World Health Organization classification described as carrying the specific 11q-gain/loss aberration and lacking MYC...
8.
Zajdel M, Rymkiewicz G, Sromek M, Cieslikowska M, Swoboda P, Kulinczak M, et al.
Cancers (Basel)
. 2019 Nov;
11(11).
PMID: 31731456
Primary central nervous system lymphoma (PCNSL) is a rare, highly aggressive, extranodal form of non-Hodgkin lymphoma, predominantly diagnosed as primary diffuse large B-cell lymphoma of the central nervous system (CNS...
9.
Rymkiewicz G, Grygalewicz B, Chechlinska M, Blachnio K, Bystydzienski Z, Romejko-Jarosinska J, et al.
Mod Pathol
. 2018 Jan;
31(5):732-743.
PMID: 29327714
We previously described a subset of MYC translocation-negative aggressive B-cell lymphomas resembling Burkitt lymphoma, characterized by proximal gains and distal losses in chromosome 11. In the 2016 WHO classification, these...
10.
Grygalewicz B, Woroniecka R, Rymkiewicz G, Rygier J, Borkowska K, Kotyl A, et al.
Am J Clin Pathol
. 2017 Dec;
149(1):17-28.
PMID: 29272887
Objectives: The latest revision of lymphoma's World Health Organization classification describes the new provisional entity "Burkitt-like lymphoma with 11q aberration" (BLL, 11q) as lacking MYC rearrangement, but harboring the specific11q-gain/loss...